HY-R01462A-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p agomir
|
|
|
|
HY-R01463-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
HY-R01463-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
HY-R01463A-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p agomir
|
|
|
|
HY-R01463A-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p agomir
|
|
|
|
HY-R03218-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03218-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03218A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p agomir
|
|
|
|
HY-R03218A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p agomir
|
|
|
|
HY-R03219-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03219-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
HY-R03219A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p agomir
|
|
|
|
HY-R03219A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p agomir
|
|
|
|
HY-RI01462-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p inhibitor
|
|
|
|
HY-RI01462-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p inhibitor
|
|
|
|
HY-RI01462A-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p antagomir
|
|
|
|
HY-RI01462A-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-3p antagomir
|
|
|
|
HY-RI01463-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p inhibitor
|
|
|
|
HY-RI01463-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p inhibitor
|
|
|
|
HY-RI01463A-20nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p antagomir
|
|
|
|
HY-RI01463A-5nmol
|
MedChemexpress LLC
|
hsa-miR-488-5p antagomir
|
|
|
|
HY-RI03218-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p inhibitor
|
|
|
|
HY-RI03218-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p inhibitor
|
|
|
|
HY-RI03218A-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p antagomir
|
|
|
|
HY-RI03218A-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p antagomir
|
|
|
|